Biocon Limited has informed the Exchange regarding a press release dated Jun 24, 2025, titled "Biocon Biologics Collaborates with National Cancer Society MalaysiaRolls Out Patient Assistance Program to Expand Affordable Access to Biosimilars".
Biocon Limited Press Release Jun 24 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Biocon
- Press Release Jun 20 2025
- Press Release Jun 09 2025
- Press Release May 08 2025
- Press Release May 05 2025
- Press Release Apr 15 2025
Later from Biocon
- Biocon Limited Press Release Jun 27 2025
- Biocon Biologics Receives Health Canada Approval for Yesafili™ (aflibercept); First Global Launch Scheduled for July 2025
- Biocon Limited Press Release Jun 30 2025
- Biocon Limited Press Release Jul 03 2025
- Biocon Limited Press Release Jul 07 2025
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon